Van Waes, C <br/><br/>
Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.  [electronic resource] 

 -  Tissue antigens  May 1996 
 - 399-407 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0001-2815 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-0039.1996.tb02575.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, Neoplasm--immunology<br/>Cancer Vaccines--immunology<br/>Carcinogens<br/>Clone Cells--immunology<br/>Cytotoxicity, Immunologic<br/>Disease Progression<br/>Female<br/>Fibrosarcoma--chemically induced<br/>H-2 Antigens--immunology<br/>Histocompatibility Antigen H-2D<br/>Immune Tolerance<br/>Immunodominant Epitopes--immunology<br/>Methylcholanthrene<br/>Mice<br/>Mice, Inbred C3H<br/>Neoplasm Transplantation--immunology<br/>Neoplasms, Radiation-Induced--chemically induced<br/>Selection, Genetic<br/>Specific Pathogen-Free Organisms<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Cells, Cultured--immunology<br/>Ultraviolet Rays--adverse effects<br/>Vaccination